162 related articles for article (PubMed ID: 37859322)
1. Huangqin-Huanglian Decoction Protects Liver against Non-alcoholic Fatty Liver Disease in High Fat-diet Mice.
Yang H; Wei D; Zhang Y; Jian W
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):691-708. PubMed ID: 37859322
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Effect and Mechanism Prediction of Fuzi-Gancao Herb Couple on Non-alcoholic Fatty Liver Disease (NAFLD) based on Network Pharmacology and Molecular Docking.
Liu K; Yang X; Zhang G; Xiang Z
Comb Chem High Throughput Screen; 2024; 27(5):773-785. PubMed ID: 37317908
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
4. Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation.
Wang L; Zhi Y; Ye Y; Zhang M; Ma X; Tie H; Ma X; Zheng N; Xia W; Song Y
Biomed Res Int; 2020; 2020():8829346. PubMed ID: 33415161
[TBL] [Abstract][Full Text] [Related]
5. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
6. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology.
Gao SS; Sun JJ; Wang X; Hu YY; Feng Q; Gou XJ
Biomed Res Int; 2020; 2020():1704960. PubMed ID: 33204683
[TBL] [Abstract][Full Text] [Related]
7. [Lipid-lowering effect of drug pair Scutellariae Radix-Coptidis Rhizoma based on lipomics].
Liu WZ; Qian XJ; Zhang JQ; Liang K; Hu C; Wang XH
Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(24):6711-6720. PubMed ID: 38212031
[TBL] [Abstract][Full Text] [Related]
8. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
[TBL] [Abstract][Full Text] [Related]
9. Identification of bioactive compounds and potential mechanisms of scutellariae radix-coptidis rhizoma in the treatment of atherosclerosis by integrating network pharmacology and experimental validation.
Ji L; Song T; Ge C; Wu Q; Ma L; Chen X; Chen T; Chen Q; Chen Z; Chen W
Biomed Pharmacother; 2023 Sep; 165():115210. PubMed ID: 37499457
[TBL] [Abstract][Full Text] [Related]
10. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways.
You L; Wang T; Li W; Zhang J; Zheng C; Zheng Y; Li S; Shang Z; Lin J; Wang F; Qian Y; Zhou Z; Kong X; Gao Y; Sun X
J Ethnopharmacol; 2024 Jul; 329():118165. PubMed ID: 38588984
[TBL] [Abstract][Full Text] [Related]
11. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation.
Zhang X; Gao R; Zhou Z; Sun J; Tang X; Li J; Zhou X; Shen T
J Ethnopharmacol; 2022 Oct; 296():115405. PubMed ID: 35644437
[TBL] [Abstract][Full Text] [Related]
12. Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
Li S; Wu X; Ma Y; Zhang H; Chen W
J Ethnopharmacol; 2023 Jul; 311():116435. PubMed ID: 37023836
[TBL] [Abstract][Full Text] [Related]
13. Integrated network pharmacology, metabolomics, and transcriptomics of Huanglian-Hongqu herb pair in non-alcoholic fatty liver disease.
Zhang X; Zhang J; Zhou Z; Xiong P; Cheng L; Ma J; Wen Y; Shen T; He X; Wang L; Zhang Y; Xiao C
J Ethnopharmacol; 2024 May; 325():117828. PubMed ID: 38325669
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the molecular mechanisms of Fuzi Lizhong Pill and Huangqin decoction in the treatment of the cold and heat syndromes of ulcerative colitis based on network pharmacology.
Hu X; Liu W; He M; Qiu Q; Zhou B; Liu R; Wu F; Huang Z
Comput Biol Med; 2023 Jun; 159():106870. PubMed ID: 37084637
[TBL] [Abstract][Full Text] [Related]
15. Molecular Targets and Mechanisms of
Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B
Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863
[TBL] [Abstract][Full Text] [Related]
16. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
[TBL] [Abstract][Full Text] [Related]
17. Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis.
Wu Y; Liu X; Li G
Sci Rep; 2022 Jan; 12(1):159. PubMed ID: 34997010
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of Astragali Radix-Puerariae Lobatae Radix combination in regulating type 2 diabetes mellitus through AMPK signaling pathway: based on network pharmacology and experimental verification].
Wei S; Li J; Han DW; Fu Q; Hao F
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2738-2749. PubMed ID: 35718494
[TBL] [Abstract][Full Text] [Related]
19. Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis.
Dang Y; Xu J; Zhu M; Zhou W; Zhang L; Ji G
Biomed Pharmacother; 2020 Jul; 127():110127. PubMed ID: 32325349
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
PeerJ; 2022; 10():e14171. PubMed ID: 36389420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
